Alcon Secures FDA Approval for TRYPTYR (Acoltremon Ophthalmic Solution) 0.003% for Dry Eye Disease
TRYPTYR, the first TRPM8-targeting eye drop, improves tear production from Day 1 in dry eye patients. Alcon (Geneva, Switzerland) has…
latest posts
TRYPTYR, the first TRPM8-targeting eye drop, improves tear production from Day 1 in dry eye patients. Alcon (Geneva, Switzerland) has…